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John B. Porter, FRCP, FRCPath, MD,§ and Somdet Srichairatanakool, PhD*Objectives: We have investigated the efficacy of mono- and combined
therapy with green tea extract (GTE) in mobilizing redox iron, scavenging
reactive oxygen species (ROS), and improving insulin production in iron-
loaded pancreatic cells.
Methods: Rat insulinoma pancreaticβ-cells were iron-loaded using culture
medium supplemented with either fetal bovine serum or ferric ammonium
citrate and treated with various doses of GTE for epigallocatechin-3-gallate
(EGCG) equivalence and in combination with iron chelators. Cellular iron,
ROS, and secretory insulin were measured.
Results: The rat insulinoma pancreatic cells took up iron from fetal bovine
serummore rapidly than ferric ammonium citrate. After treatment with GTE
(0.23–2.29 μg EGCG equivalent), cellular levels of iron and ROS were dose
dependently decreased. Importantly, secretory insulin levels were increased
nearly 2.5-fold with 2.29 μg of EGCG equivalent GTE, indicating a recovery
in insulin production.
Conclusions: Green tea EGCG ameliorated oxidative damage of iron-
loaded β-cells by removing redox iron and free radicals and attenuating in-
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636 www.pancreasjournal.comfunctions and an increase in insulin production. Green tea extract exerts
iron-chelating, free-radical scavenging, and pancreato-protective effects
in the restoration of β-cell functions, all of which we believe can increase
insulin production in diabetic β-thalassemia patients.
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I n β-thalassemiawith iron overload, the unusual forms of iron in-cluding the cytosolic labile iron pool, the plasma nontransferrin
bound iron, the labile plasma iron, and membrane nonheme iron
appear to be redox active and toxic to the cells.1–5 These various
forms of iron, particularly ferrous ion (Fe2+), catalyze the genera-
tion of reactive oxygen species (ROS) via Fenton reaction.6–8 Ex-
cessive iron is primarily accumulated in the liver, heart, and
endocrine glands, consequently causing organ dysfunction.9,10 Iron
chelators including deferoxamine (DFO), deferiprone (DFP), and
deferasirox (DFX) are used to treat patients with iron overload to
control tissue iron levels and to prevent oxidative tissue damage.11
Insulin deficiency and resistance have been reported in
β-thalassemia patients with iron overload, possibly resulting from
impaired pancreatic β-cell function.12,13 Such changes can lead to
the disturbance of glucose homeostasis.14–16 Importantly, iron
chelation therapy improves glucose homeostasis in diabetic
β-thalassemia patients.17–21 Recently, we have demonstrated that
Eltrombopag (a thrombopoietin receptor agonist with iron chelat-
ing properties) decreased cellular iron and ROS while increasing
insulin production in a rat pancreatic cell line.22
Green tea extract (GTE) containing catechin (C), epicatechin
(EC), epicatechin-3-gallate (ECG), epigallocatechin (EGC),
gallocatechin-3-gallate (GCG), and epigallocatechin-3-gallate
(EGCG) has been shown to possess iron-chelating properties as
well as pancreatoprotective activities.23–26 The influence of green
tea was investigated in pancreatic cells induced by high glucose,
cytokine, and dioxin.27–29 In this work, we have reported on the
effects of GTE on iron mobilization, ROS scavenging, and insulin
production in iron-loaded pancreatic cells.
MATERIALS AND METHODS
Chemicals and Reagents
2′,7′-Dichlorohydrofluorescin diacetate (DCFH-DA), ferric
ammonium citrate (FAC), bovine serum albumin (BSA), fetal bovine
serum (FBS), L-ascorbic acid, and 3-(2-pyridyl)-5,6-diphenyl-
1,2,4-triazine-p,p′-disulfonic acid disodium salt hydrate (ferrozine)
were acquired in the purest form available and purchased from
Sigma-Aldrich Chemicals, Company (St Louis, Mo). In addition,
DFO, DFP, DFX, C, EC, ECG, EGC, EGCG, gallic acid (GA),
gallocatechin (GC), and GAG were purchased from Sigma-
Aldrich Chemicals, Company. Lactate dehydrogenase (LDH)Pancreas • Volume 48, Number 5, May/June 2019
Pancreas • Volume 48, Number 5, May/June 2019 Green Tea Restored Iron-Loaded Pancreatic β-Cellsassay kit was purchased from Takara Bio Inc (Shiga, Japan).
Gibco RPM1 1640 medium, Krebs Ringer bicarbonate (KRB)
buffer pH 7.4, phosphate buffered saline (PBS) pH 7.0, and prote-
ase inhibitor cocktail were obtained from Thermo-Fisher Scien-
tific Company (Waltham, Mass). A sandwich ELISA kit for rat
insulin was purchased from Life Technologies Limited Company
(Paisley, United Kingdom). Rat insulinoma pancreatic (RINm5F)
cell line (ATCC CRL-11605) was obtained from American Type
Culture Collection (Manassas, Va). High-performance liquid chroma-
tography (HPLC) column (ZORBAX Eclipse Plus C18 type,
150 mm  3.0 mm, 5 μm pore size) was purchased from Agilent
Technologies Company (Santa Clara, Calif ).
GTE Preparation and Analysis
Tea (Camellia sinensis) shoots were freshly harvested from
the Doi Angkhang Tea Fields, Chiang Mai, Thailand, and poly-
phenol oxidase was immediately inactivated using a microwave
oven (800 Watts, 3 minutes, 120°C). Dry tea leaves were ground
in a blender, extracted with hot water (50 g/500 mL) at 80°C for
10 minutes, filtered through Whatman's cellulose-type paper
(Kent, United Kingdom), and lyophilized by being freeze-dried.
Green tea catechins were analyzed using reverse-phase HPLC under
the following conditions: HPLC column, mobile-phase solvent
(0.05%H2SO4/acetonitrile/ethyl acetate, 86:12:2 by volume), flow rate
1.0mL/min, andwavelength detection 280 nm. Eluentswere identified
from their specific retention times (TR), and their concentrations were
calculated in comparisonwith standard concentrations of authentic cat-
echins including GA, EGC, C, ECG, GCG, EC, GC, and EGCG
(TR = 2.305, 3.74, 4.95, 6.19, 6.76, 8.04, 10.55, and 15.81 minutes, re-
spectively).23,30 Fourmajor peakswere detected inGTE, and theywere
found to be EGC (TR = 3.705 minutes), ECG (TR = 6.054 minutes),
EGCG (TR = 16.070 minutes), and one unidentified phenolic com-
pound (TR = 20.714 minutes) (Fig. 1).
31 Our GTE containedFIGURE 1. High-performance liquid chromatography analysis of C cont
© 2019 Wolters Kluwer Health, Inc. All rights reserved.29.0 mg of EGC, 90.75 mg of ECG, and 24.75 mg of EGCG (a total
of 144.5 mg catechins) per gram dry weight and used in this study.Pancreatic Cell Culture and Iron Loading
Rat insulinoma pancreatic β-cells were cultured in RPM1
1640 medium containing 10% FBS, 100 U/mL of penicillin,
and 100 μg/mL of streptomycin.22 Cells (1 106 cells/well) were
plated on culture plates in a humidified chamber (5% CO2 atmo-
sphere, 37°C) for 24 hours awaiting 80% confluence, and the me-
dium was then removed. The cells were incubated once with
RPMI 1640 medium containing antibiotics and 10% FBS for 8
to 10 hours. After that, the medium was removed, the cells were
again combined using the same medium and incubated for 8 to
10 hours. In comparison, 80% confluent RINm5F cells were incu-
bated with FAC (1–30 μM) for 24 hours. In both iron-loading
methods, the cells were washed with PBS in the final step before
proceeding with the cellular iron measurement experiments. Via-
bility of cells was assessed by using an LDH assay according to
the manufacturer's instructions. Viable cells were also numerated
with Automated Coulter cell counters. Cell preparations with via-
bility of greater than 80% were used in all experiments.
Cellular iron was quantitated using a modified colorimetric
ferrozine assay.22 The treated cells were lysed with 200 mM of
NaOH overnight. Lysate was neutralized with 10 mM of HCl
and incubated with an iron-releasing agent comprised of 1.4 M
of HCl and 4.5% (w/v) KMnO4 (1:1, v/v) for 2 hours at room
temperature. The reaction mixture was incubated with an iron
chromogenic agent (6.5 mM ferrozine, 6.5 mM neocuproine,
2.5 M ammonium acetate, and 1 M ascorbic acid) for 30 minutes,
and the absorbance was photometrically measured at 562 nm.
Protein concentration of the cell lysate was quantitated using the
Coomassie Brilliant Blue cytophotometric method with BSA asent in GTE (10 mg/mL).
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FIGURE 2. Cellular iron in RINm5F cells incubated with medium
supplementedwith FBS (10%, once and twice) or FAC (1–30µM).
Data obtained from 3 independent experiments are expressed as
mean ± SEM. *P < 0.05when comparedwith PBS; #P < 0.05when
compared with 1.
Koonyosying et al Pancreas • Volume 48, Number 5, May/June 2019a standard.32 Cellular iron concentration was normalized against
lysate protein content and expressed as nmol/mg protein.
Iron Mobilization in RINm5F Cells
In monotherapy, iron-loaded RIN5mF cells were treated with
different concentrations of GTE (1 and 10 μM EGCG), and iron
chelators (10 μM each) as DFO, DFP, and DFX at 37°C for 0 to
12 hours. In the combined therapy, iron-loaded RIN5mF cells
were treated with GTE (1–10 μM EGCG) together with the chela-
tors (10 μM each) for 12 hours. Cellular iron concentration was de-
termined by using a modified ferrozine assay.33 The treated cells
were lysed with 200 mM of NaOH overnight, then neutralized with
10 mM of HCl, and incubated with an iron-releasing agent consti-
tuting 1.4 M of HCl and 4.5% (w/v) KMnO4 (1:1, v/v) for 2 hours
at room temperature. The lysate was incubated with an iron chro-
mogenic agent (6.5 mM ferrozine, 6.5 mMneocuproine, 2.5M am-
monium acetate, and 1 M ascorbic acid) for 30 minutes, and
absorbance was measured at 562 nm. Iron concentration was nor-
malized against protein content and expressed as nmol/mg protein.
Reduction of ROS in RINm5F Cells
Iron-loaded RIN5mF cells were washed with sterile PBS, la-
beled with 9 μMofDCFH-DA solution for 30minutes and treated
with GTE (1–10 μMEGCG), and the chelators (10 μMeach) were
treated for 60 minutes at 37°C under the kinetics system in a mi-
croplate reader. Fluorescence intensity was measured with a
spectrofluorometer (λex = 493 nm/λem = 522 nm).
34
Evaluation for Response of Insulin Secretion
in RINm5F Cells
To optimize cellular iron overload with minimal effect on
insulin production, cells were loaded with iron using a recently
published protocol.22 Rat insulinoma pancreatic cells that were
sensitive to glucose challenges were used to investigate insulin secre-
tion. After being loaded with 10% FBS or 25% FBS (once or twice),
the cells were challenged with KRB buffer (119mMNaCl, 4.74mM
KC1, 2.54 mM CaC12, 1.19 mM MgC12, 1.19 mM KH2PO4,
25mMNaHCO3, pH 7.4) containing 0.5%BSA and 2.8mMof glu-
cose for 1 hour. After that, the remaining buffer was switched to the
KRB buffer containing 16.7 mMof glucose for 1 hour. The super-
natant was then collected for the quantification of insulin using a
standard rat insulin ELISA kit. The remaining cells were washed
once with ice-cold PBS (pH 7.4) containing the protease inhibitor
cocktail. Iron and protein concentrations of the cell lysates were
measured using the established methods as described previously.
Cellular iron concentrations were normalized with cellular protein
concentrations and are expressed as nmol/mg protein.
In another experiment, RINm5F cells were iron loaded with
25% FBS twice and treated with GTE (1–20 μM EGCG) or iron
chelators (1 and 10 μM each) for 8 hours. The treated cells were
switched to be incubated in KRB buffer containing 0.5% BSA
and 2.8 mM of glucose for 1 hour and then consecutively in
16.7 mM glucose for 1 hour. Secretory insulin concentrations in
the medium were determined using the ELISA method as de-
scribed previously and are expressed as pU/mL.
Statistical Analysis
Data were analyzed using IBM SPSS Statistics version 22
(Armonk, NY) program and are presented as mean ± standard
error of the mean (SEM). Statistical significance was deter-
mined using 1-way analysis of variance, in which P < 0.05 was
considered significant.638 www.pancreasjournal.comRESULTS
Iron Loading in Pancreatic Cell Culture
The RIN5mF pancreatic β-cell line was iron overloaded
using 2 iron sources, 10% FBS and FAC. Cellular iron levels were
markedly increased in proportion to the frequency of the FBS
change (1 and 2 times) and the dose dependence of FAC. Fetal bo-
vine serum loaded iron into the cells more efficiently than FAC
(Fig. 2). The result suggests that FBS is an appropriate source of
iron, consistent with the work of Kakuta el al.35
Fetal bovine serum and FAC (1–10 μM, except 30 μM) were
found to not be harmful to the cells based on LDH assay. This
finding was consistent with the automated cell counter assay,
where cell viability was greater than 80% when cultured in the
medium containing the FBS and the FAC (data not shown). Green
tea extract treatment (1–30 μM EGCG) tended to be toxic to the
cells, as judged by LDH release in a dose-dependent manner. In-
creased release of LDH into the medium was observed and is shown
in Supplemental Figure 1 (http://links.lww.com/MPA/A721). We
conducted experiments where only viability exceeded 80%
(1%–20% LDH leakage). The concentrations of GTE between 1
and 20 μM of EGCG showed levels of LDH equivalence up to
20%. This concentration range was therefore chosen to perform
further experiments. Viability of the cells treated with GTE
(1 μM EGCG equivalence) and justified by LDH leaving was
well maintained.Iron Mobilization in Iron-Loaded Cells by GTE
At 8 hours, GTE at quantities of 1 and 10 μM EGCG
displayed high levels of efficacy in the mobilizing of cellular iron
in iron-overloaded RINm5F cells, in which the iron mobilization
was dependent upon the concentrations during 2 to 6 hours of
treatment (Fig. 3). Similarly, reference iron chelators (10 μMeach)
presented effective ironmobilization over 8 hours, and this outcome
remained steady after this time point. The relative degree of initial
iron mobilization in the treated cells was 10 μM DFX > 10 μM
DFO > 10 μM DFP, 10 μM-EGCG GTE > 1 μM-EGCG GTE.
Thus, not only were standard chelators able to gain access to iron
overloaded cells and remove chelatable iron but green tea also
displayed this function.© 2019 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 3. Time-course mobilization of iron in iron-loaded RINm5F
cells treated with GTE (1 and 10 μM EGCG) and DFO, DFP, and
DFX (10 μM each). Data obtained from 3 independent experiments
are expressed as mean ± SEM.
Pancreas • Volume 48, Number 5, May/June 2019 Green Tea Restored Iron-Loaded Pancreatic β-CellsAs is shown in Figure 4, all 3 chelators (10 μMeach) effectively
removed iron from RINm5F cells (P < 0.05) with the relative de-
gree of DFX > GTE > DFP ≈ DFO. Interestingly, GTE (1 and
10 μM EGCG) monotherapy decreased the amount of cellular
iron in a concentration-dependent manner (P < 0.05), whereas
GTE at 10 μMEGCG showed almost a 2-fold decrease in intracel-
lular iron when compared with the nontreatment. At 1 μMEGCG,
iron release was significant but without substantial effect on LDH
release. The combinations (GTE [1 μM EGCG] + 10 μM DFO)
and (GTE [10 μMEGCG] + 10 μMDFO) presented a synergistic
effect of intracellular ironmobilization.However, DFP andDFXonly
showed trends of synergism when combinations of GTE (10 μM
EGCG) with the chelators (10 μM each) were used, respectively.
ROS Levels in Iron-Loaded Cells After
GTE Treatment
Green tea extract (1–10 μM EGCG) monotherapy clearly re-
duced cellular ROS levels in a concentration-dependent manner
(P < 0.05) (Fig. 5). When compared with standard chelator
(10 μM) monotherapy, the higher GTE dose was more efficientFIGURE 4. Dose-response mobilization of iron in iron-loaded RINm5F ce
chelators as DFO, DFP, and DFX (10 μM each). Data obtained from 3 in
when compared with PBS; #P < 0.05 when compared with consecutive
© 2019 Wolters Kluwer Health, Inc. All rights reserved.at removing cellular iron and gave better results than the chelators
at equivalent concentrations (P < 0.05). When iron chelators were
added toGTE, decrement in ROSwas still observed alongwith in-
creasing GTE values (P < 0.05). However, with the exception of
DFP, ROS was not found to be significantly less than with GTE.
Thus, a combination of GTE and DFP displayed higher efficacy
in lowering cellular ROS than the other 2 chelators (P < 0.05).
Our findings suggest that green tea possesses high antioxidant ac-
tivity and a powerful free-radical scavenging capacity.
Response of Pancreatic β-Cell Function to
GTE Treatment
When RINm5F cells were loaded with iron and became subject
to oxidative stress, insulin synthesis would be affected.Wewish to
determine whether this leads to decreased insulin production
while cell viability was unchanged. We predicted that GTE and
the chelator treatment might restore β-cell functions in iron
overloaded RINm5F cells and consequently increase insulin
production/secretion. As is shown in Figure 6, cellular iron con-
centrations were increased, and secretory insulin levels were de-
creased sequentially after being loaded with 10% FBS (once
and twice) or 25% FBS (once and twice). Ten percent FBS me-
dium (twice) was found to be more suitable than 25% FBS for
loading iron into RINm5F cells, thereby generating the highest
value of insulin secretion.
Importantly, monotherapy with GTE (1–20 μM EGCG) was
found to have dose increased insulin secretion from iron loaded
RINm5F cells (P < 0.05), but the viability of the cells was still well
maintained (Fig. 7). Green tea extract and the 3 other chelators in-
creased the insulin production in a concentration-dependentmanner
(P < 0.05). In this case, GTE was less efficient than 1 μM of DFX
but most effective at 10 μM (Fig. 8). The results suggest that GTE
itself and its combination with iron chelators could restore pancre-
atic β-cell function from oxidative damage and improve insulin
secretion under iron overloaded conditions.CONCLUSIONS
Diabetes is an endocrinopathy complication commonly
found in nontransfusion-dependent and transfusion-dependent
β-thalassemia patients who have accumulated iron in the pancreatic
islets of β-cells.13,17 Plasma membrane metal transporters such aslls treated with PBS, GTE, and a combination of GTE with iron
dependent experiments are expressed as mean ± SEM. *P < 0.05
lower concentrations.
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FIGURE 5. Reactive oxygen species levels in iron-loaded RINm5F cells treated with PBS, GTE, and GTE combined with DFO, DFP, and DFX
(10 μMeach). Data obtained from3 independent experiments are expressed asmean ± SEM. *P < 0.05when comparedwith PBS; #P < 0.05
when compared with consecutive lower concentrations.
Koonyosying et al Pancreas • Volume 48, Number 5, May/June 2019divalent metal transporters Zip14 and Zip1836,37 and/or L-type volt-
age dependent calcium channel38 contribute to taking up iron,
mostly nontransferrin bound iron, into pancreatic β-cells. Two rat
insulinoma pancreatic β-cell lines, RIM5mFand INS-1, are usually
used for investigating the effects of glucose-induced insulin secre-
tion. Bovine serum contains sources of iron including ferritin,
whereas transferrin can supply iron to cultured RINm5F cells.39
In this study, we used fetal bovine serum, which was less toxic to
RINm5F cells than ferric ammonium citrate, while achieving the
iron overload of our pancreatic cell lines.
Green tea extract and the EGCG fraction were found to ame-
liorate iron overload and oxidative stress levels in the livers and
hearts of β-thalassemia mice.23,40 Here, this work has been ex-
tended to pancreatic β-cells. Epigallocatechin-3-gallate can delay
the onset of insulin-dependent diabetic mellitus in mice and re-
lieve the inflammation of pancreatic β-cells.27,41,42 However, it
has also been reported that green tea EGCG is a potential prooxi-
dant that can induce oxidative damage to the HIT-T15 pancreatic
β-cell line.43 This is relevant to our findings where we show that
EGCG-rich GTE can cause cell damage, as is seen by high extra-
cellular LDH levels when high doses of GTE were used. BecauseFIGURE 6. Response of insulin production in RINm5F cells
incubated in FBS-supplemented RPMI medium once or twice.
Data obtained from 3 independent experiments are expressed as
mean ± SEM. #P < 0.05 when compared with PBS.
640 www.pancreasjournal.comGTE is associated with increased LDH release at higher concen-
trations, the possibility of cell damage leading to the release of
preformed rather than active insulin cannot be excluded. However,
some evidence and experiments are mentioned in support of this.
Lactate dehydrogenase expression and activity were found to be
low in the pancreatic insulinoma (INS-1) β-cells; however, LDH
overexpression was capable of highly increasing cellular LDH ac-
tivity but did not influence glucose-stimulated insulin secretion.44
In addition, oxidative human islet amyloid polypeptide was found
to induce toxicity and LDH release of the INS-1E cells, whereas
Se-enriched Spirulina extract exerted such protective effects by
preventing the ROS overproduction.45 Another study has demon-
strated that pretreatment of interleukin-1β-induced human chondro-
cyte culture with EGCG was found to decrease NO• production
and LDH leakage in a concentration-dependent manner.46
Green tea EGCG was found to protect against ROS and the
cytokine-induced β-cell destruction of RINm5F cells by reducing
levels of inducible nitric oxide synthase expression and NO• pro-
duction.27 Furthermore, EGCG was found to increase levels of
plasma insulin and anti-inflammatory cytokine interleukin-6 inFIGURE 7. Levels of insulin secreted from iron-loaded RINm5F cells
treated with various concentrations of GTE. Data obtained from 3
independent experiments are expressed as mean ± SEM. *P < 0.05
when compared nontreated cells.
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 8. Percent change of secretory insulin when compared with GTE (1 and 10 μM EGCG) and the chelators (1 and 10 μM each). Data
obtained from 3 independent experiments are expressed as mean ± SEM. *P < 0.05 when compared with PBS; #P < 0.05 when compared
with 1 μM.
Pancreas • Volume 48, Number 5, May/June 2019 Green Tea Restored Iron-Loaded Pancreatic β-Cellsnonobese diabetic mice.42 These findings demonstrate that EGCG
could be a possible natural product that is capable of inhibiting
ROS generation and decreasing diabetic mellitus progression. Im-
portantly, we have recently reported that EGCG-rich GTE was
able to reduce pancreatic iron accumulation and lipid-
peroxidation products in β-thalassemic mice with iron overload,
leading to an increase in plasma insulin production.47 In contrary,
treatment of the HIT-T15 pancreatic β-cell line with EGCG
(5–100 μM) was found to increase apoptotic cell death and cellu-
lar ROS (especially H2O2) production but decreased cell viability.
This suggests that EGCG may mediate Fe2+ formation and H2O2
generation via Haber-Weiss reaction.43 Another study revealed that in-
traperitoneal administration of EGCG (5 mg kg−1d−1) for 4 days im-
paired the β-cell response in diabetic rats, suggesting a prooxidant
effect of EGCG.48 Consistently, our study supports green tea poly-
phenols, mainly EGCG and ECG; reverse impaired function; and
decreased insulin secretion in iron overloaded-pancreatic β-cellsFIGURE 9. Diagrammatic conclusion for restoration of iron-overloaded
5′-triphosphate; EGCG-Fe3+, ferric-epigallocatechin-3-gallate complex; G
calcium channel; Tf, transferrin.
© 2019 Wolters Kluwer Health, Inc. All rights reserved.through chelating extracellular iron (such as transferrin-bound iron
in FBS), mobilizing cellular iron, and inhibiting ROS production.
The level of insulin release in the cell culture has been used
previously as a biochemical marker to predict pancreatic iron
overload and to assess the efficacy of iron chelators.49 Our find-
ings show that iron loading by bovine serum is associated with de-
creased insulin secretion to levels below or above the control
levels, whereas EGCG could restore the insulin secretion in
glucose-stimulated RIN5mF cells with iron overload. In compari-
son, the inhibitory effect of insulin secretion in an INS-1D β-cell
line by EGCG was reported.50 High doses of free radical scaven-
gers and iron chelators were ineffective in relieving oxidative
stress and were even found to be toxic to rat pancreatic cells.51
Moreover, RIM5mF cells with aweak antioxidant defense and en-
hanced autophagocytosis were very sensitive to oxidants (eg, al-
loxan) while DFO prevented such toxic effects.52 Here, the
clinically used chelators DFO, DFP, and DFX also restored insulinpancreatic β-cells by green tea treatment. ATP indicates adenosine
T2, glucose transporter-2; LTCC, L-type voltage dependent
www.pancreasjournal.com 641
Koonyosying et al Pancreas • Volume 48, Number 5, May/June 2019release while having no effect on LDH release. Depending upon
the concentration of GTE, it could act either as a potential antiox-
idant or prooxidant. This effect may also be influenced by the rel-
ative concentration and redox state of iron. The type of glucose
sensitive/insensitive insulinoma pancreatic β-cell line involved
in insulin secretion would need to be indicated as well.
Further studies are needed to assess the relationship between
the antioxidative and prooxidative effects of GTE under controlled
conditions of excess iron (II) and iron (III). Subsequent studies
would be of interest to assess whether the addition of GTE to
clinically established iron chelation regimes could improve insulin
secretion in an iron overloaded mice model and ultimately in clini-
cal practice. In conclusion, green tea, particularly EGCG, could de-
crease cellular iron, decrease ROS, and increase insulin production
in iron-loaded pancreatic cells (Fig. 9). The traditional use of sup-
plementary green tea could be helpful for glucose homeostasis in
diabetic β-thalassemia patients with iron overload.
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